Skip to main content
Clinical Trials/NCT02247024
NCT02247024
Completed
Not Applicable

Dynamic Assessment of Pupillary Reflex in Patients on High-dose Opioids

Oslo University Hospital2 sites in 1 country63 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
Oslo University Hospital
Enrollment
63
Locations
2
Primary Endpoint
Pupillary reflexes
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Evaluation of pupillary reflex in patients on high-dose opioids. Clinical assessment of pain intensity, sedation score, and other side effects of opioids. Measurements of the concentration of opioids and their active metabolites in blood.

Detailed Description

Pupil size reflects the balance between sympathetic and parasympathetic systems. Pupil size and reaction are also influenced by drugs, where opioids result in miosis, an effect that is not considered to be influenced by opioid tolerance. However, cancer patients on high-dose opioids do not always present small pupil size. We want to perform a dynamic assessment of pupillary reflex in patients on high-dose opioids. In addition to pupil size measurements under standard room light conditions, two pupil size reflexes will by assessed: the pupillary light reflex when the pupil is exposed to light, and the reflex dilation during a standardized noxious stimulus. On the same time we will assess pain intensity, sedation score, and other side effects of opioids while measuring the concentration of opioids and their active metabolites in blood. In addition we will register all concomitant medication that also might influence pupil size and reaction. Patients on more than 60 morphine equivalents pr day will be included.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
November 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ulf Kongsgaard

Professor

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • In-patients and out-patients at Oslo University Hospital with cancer pain who have use opioids (morphine, oxycodone, fentanyl or methadone or a combination of these drugs) at least for periods of 4 weeks, and use opioids corresponding to at least 60 mg oral morphine equivalents pr day

Exclusion Criteria

  • Patients who have undergone eye-surgery that may influence pupillary reflexes
  • Patients on local medication that may influence pupillary reflexes
  • Patients with amyloidosis, multiple sclerosis, Horner's syndrome, or ongoing migraine attack
  • Patients with brain tumor

Outcomes

Primary Outcomes

Pupillary reflexes

Time Frame: One year

Dynamic pupillometry

Secondary Outcomes

  • Opioid and metabolite concentration(One year)

Study Sites (2)

Loading locations...

Similar Trials